
CPL Pharmaceuticals Private Limited
About CPL Pharmaceuticals Private Limited
Data last updated:
CPL Pharmaceuticals Private Limited is a private limited company based in Ahmedabad, Gujarat, India, a subsidiary of Cadila Pharmaceuticals Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24299GJ2021PTC119244. Its GSTIN is 24AAJCC2124P1ZL (Gujarat). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹80.28 Cr. It is led by directors including Biswajit Mitra (Whole-Time Director) and Ramesh Ratilal Choksi.
Its last annual general meeting (AGM) was held on 29 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 709 Cadila Corporate Campus – At Bhat Sarkhej – Dholka Road, Ahmedabad, Gujarat, India – 382210.
As per the financials filed for FY 2025, the company reported a revenue of ₹38.02 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹54.26 Cr (net margin -142.7%) and EBITDA of -₹19.36 Cr (EBITDA margin -50.9%).
The company has about 167 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹434.55 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
CPL Pharmaceuticals Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address709 Cadila Corporate Campus – At Bhat Sarkhej – Dholka Road, Ahmedabad, Gujarat, India – 382210
- IndustryPharma, Drug Formulation & Development
To see the full contact details of CPL Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of CPL Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of CPL Pharmaceuticals Private Limited, buy the company report.
Financials of CPL Pharmaceuticals Private Limited
FY 2025 filings availableCPL Pharmaceuticals Private Limited reported revenue of ₹38.02 Cr (up 1237% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹19.36 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹54.26 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -50.9% | ||||
| Net Profit Margin | -142.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of CPL Pharmaceuticals Private Limited, buy the company report.
Board of directors and KMP of CPL Pharmaceuticals Private Limited
CPL Pharmaceuticals Private Limited currently reports 5 directors and 1 key managerial person. 4 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mitul Maheshkumar Dave Also directs: Apollo Hospitals International Limited | Cfo | 19 Jan 2022 | 4 Years 9 Months | Current |
| Ramesh Ratilal Choksi Also directs: CPL Biologicals Private Limited, La Vie Biologicals Private Limited, Gig - Irm Glass Insulators Private Limited and 5 more | Director | 01 Jan 2021 | 5 Years 10 Months | Current |
| Amitabha Banerjee | Director | 19 Jan 2022 | 4 Years 9 Months | Current |
| Rajiv Rajiv Modi Also directs: Irm Energy Limited, CPL Biologicals Private Limited, La Vie Biologicals Private Limited and 5 more | Director | 16 Jul 2024 | 2 Years 4 Months | Current |
| Biswajit Mitra | Whole-Time Director | 18 Oct 2024 | 2 Years 0 Months | Current |
| Kamlesh Navaratnalal Shah | Director | 08 May 2023 | 3 Years 6 Months | Current |
Peer comparison
CPL Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vip Pharmaceuticals Private Limited | ₹40.07 Cr (FY 2025) | 6.0% | New Delhi, Delhi, India | |||
| CPL Pharmaceuticals Private Limitedthis company | ₹38.02 Cr (FY 2025) | -₹54.26 Cr | -142.7% | 1237.0% | 167 | Ahmedabad, Gujarat, India |
| Nandesari Drugs and Pharmaceuticals Private Limited | ₹37.08 Cr (FY 2024) | 1417.0% | Delhi, India | |||
| Shukra Pharmaceuticals Limited | ₹36.79 Cr (FY 2025) | -52.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of CPL Pharmaceuticals Private Limited, buy the company report.
Auditor
CPL Pharmaceuticals Private Limited is audited by MUKESH M. SHAH & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MUKESH M. SHAH & CO | FY 2022 | 106625W |
Shareholding
The shareholding of CPL Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of CPL Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Aug 2023 | 100763813 | Others | ₹198.98 Cr | Open | |
| 29 Sep 2022 | 100614672 | Others | ₹235.57 Cr | Open |
To see the full charge records of CPL Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
CPL Pharmaceuticals Private Limited has 1 court case on record: 1 filed by CPL Pharmaceuticals. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Rajasthan | Writ petition | Filed by the company against State of Rajasthan | Pending |
To see the full case history of CPL Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
CPL Pharmaceuticals Private Limited has 3 MSME Form 1 returns on record between 2023 and 2024, listing 33 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Vimit Construction | |||
| Aevitas Pharmagro Tech Private Limited | |||
| Chemtek Fiberglass Private Limited | |||
| S2 Engineering Industry Private Limited | |||
| an individual supplier |
To see the full MSME payment records of CPL Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
CPL Pharmaceuticals Private Limited has a workforce of 167 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 167 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of CPL Pharmaceuticals Private Limited, buy the company report.
GST
CPL Pharmaceuticals has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAJCC2124P1ZL | Gujarat | Active | 09 Aug 2021 |
| 08AAJCC2124P1ZF | Rajasthan | Active | 03 Feb 2021 |
| 01AAJCC2124P1ZT | Jammu and Kashmir | Active | 07 Aug 2024 |
To see the full GST registrations and return filing status of CPL Pharmaceuticals Private Limited, buy the company report.
Recent activity
CPL Pharmaceuticals Private Limited has 10 board changes on record since 2021: 8 appointments and 2 cessations. The latest: Jignesh Shashikant Desai ceased to be Director on 23 Jun 2025.
4 earlier events are in the company report.
Frequently asked questions
CPL Pharmaceuticals is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 January 2021 (5+ years old) and is registered under CIN U24299GJ2021PTC119244.
CPL Pharmaceuticals has 6 current directors and KMP:
- Biswajit Mitra - Whole-Time Director
- Ramesh Ratilal Choksi - Director
- Amitabha Banerjee - Director
- Rajiv Rajiv Modi - Director
- Kamlesh Navaratnalal Shah - Director
- Mitul Maheshkumar Dave - Cfo
The latest financial statements of CPL Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 August 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of CPL Pharmaceuticals is 24AAJCC2124P1ZL, registered in Gujarat. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 08AAJCC2124P1ZF (Rajasthan), 01AAJCC2124P1ZT (Jammu and Kashmir).
The CIN (Corporate Identification Number) of CPL Pharmaceuticals is U24299GJ2021PTC119244. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
CPL Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
CPL Pharmaceuticals was incorporated on 01 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of CPL Pharmaceuticals by revenue are Vip Pharmaceuticals Private Limited, Nandesari Drugs and Pharmaceuticals Private Limited, Shukra Pharmaceuticals Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jignesh Shashikant Desai ceased to be Director on 23 Jun 2025. Biswajit Mitra was appointed as Whole-Time Director on 18 Oct 2024. Jignesh Shashikant Desai was appointed as Director on 18 Oct 2024. CPL Pharmaceuticals has 10 board changes on record in total.
CPL Pharmaceuticals has 3 MSME Form 1 returns on record between 2023 and 2024, listing 33 overdue payments to 6 micro and small suppliers. The latest return was filed on 01 May 2024.
The registered office of CPL Pharmaceuticals is at 709 Cadila Corporate Campus – At Bhat Sarkhej – Dholka Road, Ahmedabad, Gujarat, India – 382210.
CPL Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

